LF
GILD icon

Lansforsakringar Fondforvaltning’s Gilead Sciences GILD Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96M Sell
689,133
-3,182
-0.5% -$446K 0.5% 32
2025
Q4 		$85M Buy
692,315
+97,872
+16% +$11.9M 0.42% 38
2025
Q3 		$66M Buy
594,443
+210,244
+55% +$23.9M 0.34% 50
2025
Q2 		$42.6M Sell
384,199
-20,201
-5% -$2.15M 0.24% 79
2025
Q1 		$45.3M Sell
404,400
-14,275
-3% -$1.47M 0.28% 77
2024
Q4 		$38.7M Buy
+418,675
New +$37.7M 0.22% 91

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lansforsakringar Fondforvaltning's GILD Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its Gilead Sciences (GILD) stake by 0.46% in Q1 2026, selling an estimated $446K and leaving 689,133 shares worth $96M. The position accounts for 0.5% of the portfolio, ranked #32.

Lansforsakringar Fondforvaltning first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 689,133 shares of Gilead Sciences worth $96M as of Q1 2026.
  • Lansforsakringar Fondforvaltning sold 3,182 Gilead Sciences shares in Q1 2026, an estimated $446K.
  • Gilead Sciences made up 0.5% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #32 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.